21 USC 1708 - Emerging Threats Committee, plan, and media campaign

U.S Code last checked for updates: Nov 22, 2024

§ 1708.

Emerging Threats Committee, plan, and media campaign

(a)

Emerging and Continuing Threats Coordinator

(b)

Emerging Threats Committee

(1)

In general

The Emerging Threats Committee shall—

(A)

monitor evolving and emerging drug threats in the United States;

(B)

identify and discuss evolving and emerging drug trends in the United States using the criteria required to be established under paragraph (6);

(C)

assist in the formulation of and oversee implementation of any plan described in subsection (d);

(D)

provide such other advice to the Coordinator and Director concerning strategy and policies for emerging drug threats and trends as the Committee determines to be appropriate; and

(E)

disseminate and facilitate the sharing with Federal, State, local, and Tribal officials and other entities as determined by the Director of pertinent information and data relating to—

(i)

recent trends in drug supply and demand;

(ii)

fatal and nonfatal overdoses;

(iii)

demand for and availability of evidence-based substance use disorder treatment, including the extent of the unmet treatment need, and treatment admission trends;

(iv)

recent trends in drug interdiction, supply, and demand from State, local, and Tribal law enforcement agencies; and

(v)

other subject matter as determined necessary by the Director.

(2)

Chairperson

(3)

Members

The Director shall appoint other members of the Committee, which shall include—

(A)

representatives from National Drug Control Program agencies or other agencies;

(B)

representatives from State, local, and Tribal governments; and

(C)

representatives from other entities as designated by the Director.

(4)

Meetings

(5)

Contract, agreement, and other authority

(6)

Criteria to identify emerging drug threats

(c)

Designation

(1)

In general

(2)

Standards for designation

(3)

Public statement required

(d)

Plan

(1)

Public availability of plan

(2)

Timing

(3)

Contents of an emerging threat response plan

The Director shall include in the plan required under this subsection—

(A)

a comprehensive strategic assessment of the emerging drug threat, including the current availability of, demand for, and effectiveness of evidence-based prevention, treatment, and enforcement programs and efforts to respond to the emerging drug threat;

(B)

comprehensive, research-based, short- and long-term, quantifiable goals for addressing the emerging drug threat, including for reducing the supply of the drug designated as the emerging drug threat and for expanding the availability and effectiveness of evidence-based substance use disorder treatment and prevention programs to reduce the demand for the emerging drug threat;

(C)

performance measures pertaining to the plan’s goals, including quantifiable and measurable objectives and specific targets;

(D)

the level of funding needed to implement the plan, including whether funding is available to be reprogrammed or transferred to support implementation of the plan or whether additional appropriations are necessary to implement the plan;

(E)

an implementation strategy for the media campaign under subsection (f), including goals as described under subparagraph (B) of this paragraph and performance measures, objectives, and targets, as described under subparagraph (C) of this paragraph; and

(F)

any other information necessary to inform the public of the status, progress, or response to an emerging drug threat.

(4)

Implementation

(A)

In general

(B)

Coordinator’s responsibilities

The Coordinator shall—

(i)

direct the implementation of the plan among the agencies identified in the plan, State, local, and Tribal governments, and other relevant entities;

(ii)

facilitate information-sharing between agencies identified in the plan, State, local, and Tribal governments, and other relevant entities; and

(iii)

monitor implementation of the plan by coordinating the development and implementation of collection and reporting systems to support performance measurement and adherence to the plan by agencies identified in the plan, where appropriate.

(C)

Reporting

(e)

Evaluation of media campaign

(f)

National anti-drug media campaign

(1)

In general

The Director shall, to the extent feasible and appropriate, conduct a national anti-drug media campaign (referred to in this subsection as the “national media campaign”) in accordance with this subsection for the purposes of—

(A)

preventing substance abuse among people in the United States;

(B)

educating the public about the dangers and negative consequences of substance use and abuse, including patient and family education about the characteristics and hazards of substance abuse and methods to safeguard against substance use, to include the safe disposal of prescription medications;

(C)

supporting evidence-based prevention programs targeting the attitudes, perception, and beliefs of persons concerning substance use and intentions to initiate or continue such use;

(D)

encouraging individuals affected by substance use disorders to seek treatment and providing such individuals with information on—

(i)

how to recognize addiction issues;

(ii)

what forms of evidence-based treatment options are available; and

(iii)

how to access such treatment;

(E)

combating the stigma of addiction and substance use disorders, including the stigma of treating such disorders with medication-assisted treatment therapies; and

(F)

informing the public about the dangers of any drug identified by the Director as an emerging drug threat as appropriate.

(2)

Use of funds

(A)

In general

Amounts made available to carry out this subsection for the national media campaign may only be used for the following:

(i)

The purchase of media time and space, including the strategic planning for, tracking, and accounting of, such purchases.

(ii)

Creative and talent costs, consistent with subparagraph (B)(i).

(iii)

Advertising production costs, which may include television, radio, internet, social media, and other commercial marketing venues.

(iv)

Testing and evaluation of advertising.

(v)

Evaluation of the effectiveness of the national media campaign.

(vi)

Costs of contracts to carry out activities authorized by this subsection.

(vii)

Partnerships with professional and civic groups, community-based organizations, including faith-based organizations, and government organizations related to the national media campaign.

(viii)

Entertainment industry outreach, interactive outreach, media projects and activities, public information, news media outreach, and corporate sponsorship and participation.

(ix)

Operational and management expenses.

(B)

Specific requirements

(i)

Creative services

In using amounts for creative and talent costs under subparagraph (A)(ii), the Director shall use creative services donated at no cost to the Government wherever feasible and may only procure creative services for advertising—

(I)

responding to high-priority or emergent campaign needs that cannot timely be obtained at no cost; or

(II)

intended to reach a minority, ethnic, or other special audience that cannot reasonably be obtained at no cost.

(ii)

Testing and evaluation of advertising

(iii)

Consultation

For the planning of the campaign under paragraph (1), the Director may consult with—

(I)

the head of any appropriate National Drug Control Program agency;

(II)

experts on the designated drug;

(III)

State, local, and Tribal government officials and relevant agencies;

(IV)

communications professionals;

(V)

the public; and

(VI)

appropriate congressional committees.

(iv)

Evaluation of effectiveness of national media campaign

In using amounts for the evaluation of the effectiveness of the national media campaign under subparagraph (A)(v), the Director shall—

(I)

designate an independent entity to evaluate by April 20 of each year the effectiveness of the national media campaign based on data from—

(aa)

the Monitoring the Future Study published by the Department of Health and Human Services;

(bb)

the National Survey on Drug Use and Health; and

(cc)

other relevant studies or publications, as determined by the Director, including tracking and evaluation data collected according to marketing and advertising industry standards; and

(II)

ensure that the effectiveness of the national media campaign is evaluated in a manner that enables consideration of whether the national media campaign has contributed to changes in attitude or behaviors among the target audience with respect to substance use and such other measures of evaluation as the Director determines are appropriate.

(3)

Advertising

(4)

Responsibilities and functions under the program

(A)

In general

(B)

Director

(i)

In general

The Director shall approve—

(I)

the strategy of the national media campaign;

(II)

all advertising and promotional material used in the national media campaign; and

(III)

the plan for the purchase of advertising time and space for the national media campaign.

(ii)

Implementation

The Director shall be responsible for implementing a focused national media campaign to meet the purposes set forth in paragraph (1) and shall ensure—

(I)

information disseminated through the campaign is accurate and scientifically valid; and

(II)

the campaign is designed using strategies demonstrated to be the most effective at achieving the goals and requirements of paragraph (1), which may include—

(aa)

a media campaign, as described in paragraph (2);

(bb)

local, regional, or population specific messaging;

(cc)

the development of websites to publicize and disseminate information;

(dd)

conducting outreach and providing educational resources for parents;

(ee)

collaborating with law enforcement agencies; and

(ff)

providing support for school-based public health education classes to improve teen knowledge about the effects of substance use.

(5)

Prohibitions

None of the amounts made available under paragraph (2) may be obligated or expended for any of the following:

(A)

To supplant current anti-drug community-based coalitions.

(B)

To supplant pro bono public service time donated by national and local broadcasting networks for other public service campaigns.

(C)

For partisan political purposes, or to express advocacy in support of or to defeat any clearly identified candidate, clearly identified ballot initiative, or clearly identified legislative or regulatory proposal.

(D)

To fund advertising that features any elected officials, persons seeking elected office, cabinet level officials, or other Federal officials employed pursuant to section 213 of Schedule C of title 5, Code of Federal Regulations.

(E)

To fund advertising that does not contain a primary message intended to reduce or prevent substance use.

(F)

To fund advertising containing a primary message intended to promote support for the national media campaign or private sector contributions to the national media campaign.

(6)

Matching requirement

(A)

In general

(B)

No-cost match advertising direct relationship requirement

(C)

No-cost match advertising not directly related

(7)

Financial and performance accountability

(A)

audits and reviews of costs of the national media campaign pursuant to section 4706 of title 41; and

(B)

an audit to determine whether the costs of the national media campaign are allowable under chapter 43 of title 41.

(8)

Report to Congress

The Director shall submit on an annual basis a report to Congress that describes—

(A)

the strategy of the national media campaign and whether specific objectives of the national media campaign were accomplished;

(B)

steps taken to ensure that the national media campaign operates in an effective and efficient manner consistent with the overall strategy and focus of the national media campaign;

(C)

plans to purchase advertising time and space;

(D)

policies and practices implemented to ensure that Federal funds are used responsibly to purchase advertising time and space and eliminate the potential for waste, fraud, and abuse;

(E)

all contracts entered into with a corporation, partnership, or individual working on behalf of the national media campaign;

(F)

the results of any financial audit of the national media campaign;

(G)

a description of any evidence used to develop the national media campaign;

(H)

specific policies and steps implemented to ensure compliance with this section;

(I)

a detailed accounting of the amount of funds obligated during the previous fiscal year for carrying out the national media campaign, including each recipient of funds, the purpose of each expenditure, the amount of each expenditure, any available outcome information, and any other information necessary to provide a complete accounting of the funds expended; and

(J)

a review and evaluation of the effectiveness of the national media campaign strategy for the past year.

(9)

Required notice for communication from the Office

(g)

Authorization of appropriations

(Pub. L. 105–277, div. C, title VII, §§ 709, 715, Oct. 21, 1998, 112 Stat. 2681–688, 2681–693; Pub. L. 109–469, title V, § 501(a), title VI, § 602, Dec. 29, 2006, 120 Stat. 3527, 3533; Pub. L. 115–271, title VIII, §§ 8202(a), (b)(2), 8218(a), Oct. 24, 2018, 132 Stat. 4110, 4125; Pub. L. 116–74, § 2(a)(1), (2), (8), Nov. 27, 2019, 133 Stat. 1155, 1157.)

cite as: 21 USC 1708